Katarzyna Kaleta

Metabolic Disorders/Obesity Is a Primary Risk Factor in Hidradenitis Suppurativa: An Immunohistochemical Real-World Approach

Katarzyna Kaleta, Georgios Nikolakis, Amir M. Hossini et al. · Dermatology · 2021 · 41 citations · Full text

Case Report: PsAPSASH syndrome: an alternative phenotype of syndromic hidradenitis suppurativa treated with the IL-17A inhibitor secukinumab

Georgios Nikolakis, Katja Kreibich, Katarzyna Kaleta et al. · F1000Research · 2021 · 24 citations · Full text

Immunology, Skin Symptoms, Dermatology +21

Immunosuppressory activity of an isoxazolo[5,4-e]triazepine-compound RM-33 II. Effects on the carrageenan-induced inflammation.

Michał Zimecki, Stainsław Ryng, Marcin Mą̨czyński et al. · PubMed · 2006 · 16 citations

Synthesis and Antiviral Properties of Aza-Analogues of<i>Acyclovir</i>

Mariola Koszytkowska‐Stawińska, Katarzyna Kaleta, Wojciech Sas et al. · Nucleosides Nucleotides & Nucleic Acids · 2006 · 15 citations

Medicinal Chemistry, Specific Antiviral Effects, One-pot Base Silylation/nucleoside +13

Case Report: PsAPSASH syndrome: an alternative phenotype of syndromic hidradenitis suppurativa treated with the IL-17A inhibitor secukinumab

Georgios Nikolakis, Katja Kreibich, Katarzyna Kaleta et al. · F1000Research · 2021 · 11 citations · Full text

Immunology, Dermatology, Psoriatic Arthritis +19